Jun 10, 2024
Three-dimensional models of skeletal muscle under tension and methods to induce traumatic injury: systematic review search protocol
- Kunal Bhanot1,
- Robert Staruch1
- 1Oxford University Hospitals NHS Foundation Trust
Protocol Citation: Kunal Bhanot, Robert Staruch 2024. Three-dimensional models of skeletal muscle under tension and methods to induce traumatic injury: systematic review search protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.q26g71m81gwz/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: June 08, 2024
Last Modified: June 10, 2024
Protocol Integer ID: 101455
Keywords: muscle model, dimensional models of skeletal muscle, relevant muscle model, relevant muscle models under tension, such muscle model, skeletal muscle, representative in vitro model, specific to the injury pattern, significant loss of skeletal muscle, traumatic injury, effects of traumatic injury, vitro model, inducing injury, muscle loss, vivo model, result of traumatic injury, injury pattern, systematic review search protocol volumetric, injury, blunt trauma, regenerative impairment, models under tension, deeper cellular picture
Abstract
Volumetric
muscle loss (VML) is defined as the significant loss of skeletal muscle as a result of traumatic injury or surgical intervention, resulting in functional and regenerative impairment. It is a considerable form of morbidity and is implicated in blast, penetrating or blunt trauma. Current research on VML is centred around models that are not specific to the injury patterns or environments usually encountered. In order to examine the effects of traumatic injury on skeletal muscle, more representative in vitro models are required to generate a deeper cellular picture prior to preclinical validation. Whilst in vivo models are invaluable, they are expensive and have a lower throughput platform for discovery research. The aim of this systematic review is to examine the types of in vitro muscle models that are applicable to understanding VML. We have therefore designed an inclusive search protocol to incorporate all relevant muscle models under tension and endeavour to subcategorise these depending on methods of inducing injury. “Skeletal muscle” was the major inclusion criterion, followed by “three dimensional” and “model”. The Ovid interface was used to search MEDLINE, EMBASE and Web of Science Core Collection databases to yield 4,895 eligible articles after de-duplication. As of 30/05/2024 articles are in the process of being blindly screened by two independent reviewers. Major inclusion criteria are three dimensional in vitro models under tension. A sub analysis will subsequently be performed to examine how injury is induced in such muscle models.
Methods
This systematic review was reported in compliance with the PRISMA 2020 checklist. The protocol was developed prospectively in collaboration with a research librarian (NT) at the Nuffield Department of Rheumatology and Musculoskeletal Sciences (NDORMS).
All databases were searched from inception until 13/03/2024. The Ovid interface was used to search MEDLINE (1946-present), EMBASE (1974-present) and Web of Science Core Collection (1900-present) databases. No date or language limits were applied. Synonyms were produced in line with elements of the research question. “Skeletal muscle” was the major inclusion criterion, followed by “three dimensional” and “model”. Synonyms for skeletal muscle included “myotube”, “slow-twitch muscle fibres” and “fast-twitch muscle fibres”. Synonyms for “three-dimensional” included “3D”, “organoid” and “lab on a chip”. Synonyms for “model” included “scaffold”, “architecture” and “platform”. Full search strategies can be found in the appendix.
Inclusion criteria
In vitro studies that utilised any skeletal muscle cell lines (primary or immortalised, single or multicellular) of any species cultured with an anchor system were eligible for inclusion. Models that used organic hydrogel compounds native to the human body (fibrin or collagen) were included. Where studies reported minor experimental modifications of previously reported models (with detailed methods), the most comprehensive study or studies were included.
Exclusion criteria
Models that did not impose axial strain or loading, self-assembly models (spheroids etc) or tissue explant models (including slice culture) were excluded. In vitro models that cultured cells on patterned surfaces (to include orientation) were also excluded, even if they used 3D systems. In vitro monolayer systems were excluded. Ex vivo perfusion systems were also excluded. Models that synthesised hydrogels using materials that were incapable of biodegradation (breakdown of organic matter into constituent elements) within humans (or human tissue) were excluded. Studies without detailed methods, opinion pieces, reviews, letters, conference abstracts, in vivo work and book chapters were excluded.
Appendix
EMBASE search:
| Total Records downloaded (enter this number here to update SearchReport tab): | 1970 | |||
| Search Strategy | ||||
| Embase 1974 to present | ||||
| 1 | skeletal myoblast/ | 596 | ||
| 2 | (skeletal adj2 myoblast*).tw,kf. | 2170 | ||
| 3 | skeletal muscle cell line/ | 83 | ||
| 4 | (cell* adj2 (stem or primary or satellite)).tw,kf. | 624478 | ||
| 5 | (myogenic or skeletal muscle).tw,kf. | 172977 | ||
| 6 | 4 and 5 | 11204 | ||
| 7 | skeletal muscle/ | 144693 | ||
| 8 | slow muscle fiber/ | 2149 | ||
| 9 | fast muscle fiber/ | 2212 | ||
| 10 | 10 | skeletal.tw,kf. | 299053 | |
| 10 | ||||
| 11 | (muscle* adj2 fiber*).tw,kf. | 35259 | ||
| 12 | 10 and 11 | 13999 | ||
| 13 | (fast-twitch or intermediate or white or type II).tw,kf. | 1117798 | ||
| 14 | (red or slow-twitch or type I).tw,kf. | 630013 | ||
| 15 | 13 or 14 | 1657758 | ||
| 16 | 11 and 15 | 6707 | ||
| 17 | myotube*.tw,kf. | 15390 | ||
| 18 | (skeletal adj2 myocyte*).tw,kf. | 751 | ||
| 19 | (myogenic or skeletal muscle).tw,kf. | 172977 | ||
| 20 | (cell* adj2 c2c12).tw,kf. | 6130 | ||
| 21 | 19 and 20 | 3398 | ||
| 22 | 1 or 2 or 3 or 6 or 7 or 8 or 9 or 12 or 16 or 17 or 18 or 21 | 171236 | ||
| 23 | 3d.tw,kf. | 324905 | ||
| 24 | three d.tw,kf. | 638 | ||
| 25 | 3 dimension*.tw,kf. | 38685 | ||
| 26 | organoid/ | 13217 | ||
| 27 | organoid*.tw,kf. | 23541 | ||
| 28 | exp lab on a chip/ | 11240 | ||
| 29 | lab on a chip.tw,kf. | 3765 | ||
| 30 | organ on a chip.tw,kf. | 1453 | ||
| 31 | exp bioengineering/ | 235895 | ||
| 32 | bioengineer*.tw,kf. | 15596 | ||
| 33 | biological engineer*.tw,kf. | 1427 | ||
| 34 | tissue engineer*.tw,kf. | 80668 | ||
| 35 | 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 | 628442 | ||
| 36 | 22 and 35 | 3934 | ||
| 37 | model*.tw,kf. | 5000672 | ||
| 38 | scaffold*.tw,kf. | 158968 | ||
| 39 | architecture*.tw,kf. | 197564 | ||
| 40 | platform*.tw,kf. | 357571 | ||
| 41 | (system or systems).tw,kf. | 4417710 | ||
| 42 | 37 or 38 or 39 or 40 or 41 | 8919326 | ||
| 43 | 36 and 42 | 2505 | ||
| 44 | conference*.pt. | 5859448 | ||
| 45 | 43 not 44 | 1970 |
MEDLINE search:
| Total Records downloaded (enter this number here to update SearchReport tab): | 2650 | |||
| Search Strategy | ||||
| Medline (Ovid MEDLINE‱ Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE‱ Daily and Ovid MEDLINE‱) 1946 to present | ||||
| 1 | exp Myoblasts, Skeletal/ | 4090 | ||
| 2 | (skeletal adj2 myoblast*).tw,kf. | 1795 | ||
| 3 | (cell* adj2 (stem or primary or satellite)).tw,kf. | 422521 | ||
| 4 | (myogenic or skeletal muscle).tw,kf. | 139662 | ||
| 5 | 3 and 4 | 8576 | ||
| 6 | Muscle, Skeletal/ | 166516 | ||
| 7 | Muscle Fibers, Skeletal/ | 17604 | ||
| 8 | Muscle Fibers, Slow-Twitch/ | 2488 | ||
| 9 | Muscle Fibers, Fast-Twitch/ | 3131 | ||
| 10 | skeletal.tw,kf. | 237495 | ||
| 11 | 11 | (muscle* adj2 fiber*).tw,kf. | 29880 | |
| 11 | ||||
| 12 | 10 and 11 | 11474 | ||
| 13 | (fast-twitch or intermediate or white or type II).tw,kf. | 844075 | ||
| 14 | (red or slow-twitch or type I).tw,kf. | 493609 | ||
| 15 | 13 or 14 | 1266664 | ||
| 16 | 11 and 15 | 5555 | ||
| 17 | myotube*.tw,kf. | 12495 | ||
| 18 | (skeletal adj2 myocyte*).tw,kf. | 600 | ||
| 19 | (myogenic or skeletal muscle).tw,kf. | 139662 | ||
| 20 | (cell* adj2 c2c12).tw,kf. | 4658 | ||
| 21 | 19 and 20 | 2556 | ||
| 22 | 1 or 2 or 5 or 6 or 7 or 8 or 9 or 12 or 16 or 17 or 18 or 21 | 193945 | ||
| 23 | 3d.tw,kf. | 249537 | ||
| 24 | three d.tw,kf. | 468 | ||
| 25 | 3 dimension*.tw,kf. | 29970 | ||
| 26 | Organoids/ | 13773 | ||
| 27 | 27 | organoid*.tw,kf. | 15510 | |
| 27 | ||||
| 28 | Lab-On-A-Chip Devices/ | 7533 | ||
| 29 | lab on a chip.tw,kf. | 3690 | ||
| 30 | organ on a chip.tw,kf. | 1382 | ||
| 31 | exp Bioengineering/ | 62819 | ||
| 32 | bioengineer*.tw,kf. | 12040 | ||
| 33 | biological engineer*.tw,kf. | 432 | ||
| 34 | Tissue Engineering/ | 45681 | ||
| 35 | tissue engineer*.tw,kf. | 64407 | ||
| 36 | 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 | 387881 | ||
| 37 | 22 and 36 | 3428 | ||
| 38 | model*.tw,kf. | 3967863 | ||
| 39 | scaffold*.tw,kf. | 135360 | ||
| 40 | methods.fs. | 4360174 | ||
| 41 | architecture*.tw,kf. | 172933 | ||
| 42 | platform*.tw,kf. | 271052 | ||
| 43 | (system or systems).tw,kf. | 3641694 | ||
| 44 | 38 or 39 or 40 or 41 or 42 or 43 | 10499757 | ||
| 45 | 37 and 44 | 2650 |
Web of science search strategy:
Search
Strategy
# Search Query Database Results
1 "myotube OR (skeletal NEAR/2
myoblast*) OR ""skeletal muscle"" OR ""fast
twitch muscle fibre*"" OR ""slow twitch muscle
fibre*"" OR (skeletal NEAR/2 myocyte*) (Topic) AND 3d OR ""three
dimension*"" OR ""three d"" OR organoid* OR
""lab on a chip"" OR ""organ on a
chip"" OR bioengineer* OR ""tissue engineer*"" OR
""biological engineer*""
(Topic) AND model* OR scaffold* OR architecture* OR platform* OR system
OR systems (Topic) "
Web of
Science Core Collection 2811